Announcement PDF Market Announcement 8 October 2024 Imagion Biosystems Limited (ASX: IBX) – Trading Halt Description The securities of Imagion Biosystems Limited (‘IBX’) will be placed in trading halt at the request of IBX, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Thursday, 10 October 2024 or when the announcement is released to the market. Issued by ASX Compliance 8 October 2024 ASX Limited Market Announcement 1/1 ASX Customer Service Centre 131 279 | asx.com.au 8 October 2024 Melissa Kostopoulos ASX Limited Level 50, South Tower, Rialto 525 Collins Street MELBOURNE VIC 3000 ASX Market Announcements By email only: tradinghaltsmelbourne@asx.com.au Dear Melissa REQUEST FOR TRADING HALT IMAGION BIOSYSTEMS LIMITED (ACN 616 305 027) (ASX: IBX) Imagion Biosystems Limited (ASX: IBX) ACN 616 305 027 (Company) requests a trading halt in relation to the trading of its ordinary shares quoted on the Australian Securities Exchange (ASX) in accordance with ASX Listing Rule 17.1. The trading halt is requested pending an announcement to be made by the Company to the market in relation to a proposed capital raising. In accordance with ASX Listing Rule 17.1, the Company provides the following information in relation to the request: 1. The trading halt is necessary to assist the Company in managing its continuous disclosure obligations as the Company expects to make a material announcement to the market in relation to the stated purpose above. 2. The Company requests that the trading halt remains in place until the earlier of commencement of normal trading on Thursday, 10 October 2024, or when the announcement regarding the proposed capital raising is made. 3. The Company is not aware of any reason why the trading halt should not be granted or of any further information necessary to inform the market about the trading halt. Please contact me if you require any further information concerning this matter. Yours sincerely, Imagion Biosystems Limited Melanie Leydin Company Secretary